Compare AJANTA PHARMA with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ABBOTT INDIA AJANTA PHARMA/
ABBOTT INDIA
 
P/E (TTM) x 25.0 47.7 52.3% View Chart
P/BV x 6.9 15.4 44.9% View Chart
Dividend Yield % 0.5 0.4 114.1%  

Financials

 AJANTA PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ABBOTT INDIA
Mar-19
AJANTA PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,4228,834 16.1%   
Low Rs8985,458 16.4%   
Sales per share (Unadj.) Rs233.51,731.1 13.5%  
Earnings per share (Unadj.) Rs44.0211.9 20.7%  
Cash flow per share (Unadj.) Rs52.2219.9 23.7%  
Dividends per share (Unadj.) Rs9.0065.00 13.8%  
Dividend yield (eoy) %0.80.9 85.3%  
Book value per share (Unadj.) Rs255.1945.2 27.0%  
Shares outstanding (eoy) m88.0221.25 414.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.04.1 120.3%   
Avg P/E ratio x26.433.7 78.2%  
P/CF ratio (eoy) x22.232.5 68.4%  
Price / Book Value ratio x4.57.6 60.1%  
Dividend payout %20.530.7 66.7%   
Avg Mkt Cap Rs m102,081151,848 67.2%   
No. of employees `0006.83.5 195.1%   
Total wages/salary Rs m4,3074,356 98.9%   
Avg. sales/employee Rs Th3,022.610,555.5 28.6%   
Avg. wages/employee Rs Th633.41,249.9 50.7%   
Avg. net profit/employee Rs Th569.11,292.2 44.0%   
INCOME DATA
Net Sales Rs m20,55436,786 55.9%  
Other income Rs m2111,133 18.6%   
Total revenues Rs m20,76537,919 54.8%   
Gross profit Rs m5,6646,047 93.7%  
Depreciation Rs m721169 426.0%   
Interest Rs m1223 51.6%   
Profit before tax Rs m5,1436,989 73.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2732,485 51.2%   
Profit after tax Rs m3,8704,503 85.9%  
Gross profit margin %27.616.4 167.6%  
Effective tax rate %24.835.6 69.6%   
Net profit margin %18.812.2 153.8%  
BALANCE SHEET DATA
Current assets Rs m11,81227,610 42.8%   
Current liabilities Rs m3,7768,569 44.1%   
Net working cap to sales %39.151.8 75.5%  
Current ratio x3.13.2 97.1%  
Inventory Days Days7760 128.5%  
Debtors Days Days8227 297.8%  
Net fixed assets Rs m14,3981,057 1,362.3%   
Share capital Rs m175213 82.5%   
"Free" reserves Rs m22,27719,873 112.1%   
Net worth Rs m22,45220,086 111.8%   
Long term debt Rs m70-   
Total assets Rs m26,96229,409 91.7%  
Interest coverage x444.3311.6 142.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.3 60.9%   
Return on assets %14.415.4 93.5%  
Return on equity %17.222.4 76.9%  
Return on capital %23.034.9 65.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,682369 2,895.1%   
Fx outflow Rs m2,1024,918 42.7%   
Net fx Rs m8,580-4,549 -188.6%   
CASH FLOW
From Operations Rs m3,7484,991 75.1%  
From Investments Rs m-2,228-2,570 86.7%  
From Financial Activity Rs m-1,475-1,428 103.3%  
Net Cashflow Rs m45993 4.6%  

Share Holding

Indian Promoters % 73.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 1.6 7.9 19.6%  
FIIs % 7.6 0.1 7,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 17.1 99.4%  
Shareholders   20,968 18,270 114.8%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   JUBILANT PHARMOVA   DR. DATSONS LABS  GLENMARK PHARMA  NOVARTIS  PANACEA BIOTECH  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Higher; JSW Steel & Tata Steel Top Gainers(09:30 am)

Asian share markets edged higher today as investors shrugged off concerns that stocks may have rallied too far too fast in the past year.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Mar 3, 2021 10:50 AM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS